pocketful logo light
pocketful logo light
Shilpa Medicare Ltd logo

Shilpa Medicare Ltd

NSE: SHILPAMED BSE: 530549

₹928.55

(4.37%)

Tue, 08 Sept 2026, 08:25 pm

mtf coin illustrationMTF 5x

Shilpa Medicare Share Price Live Chart

1 Day

(4.37%)

No Result Found

Summary

  • Market Cap (in Cr)

    9742.91

  • Net Profit (in Cr)

    78.3

  • P/B

    2.73

  • Sector P/E

    33.76

  • P/E

    82.77

  • EV/EBITDA

    22.66

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    4.21

  • ROCE

    7.69

  • Debt/Equity

    0.36

  • EPS (TTM)

    11.93

  • Dividend Yield

    0

  • Book Value

    132.49

  • Interest Cover

    2.94

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters40.1340.1344.2344.2344.23
FII11.0810.9710.9211.1910.97
DII8.588.337.677.467.55
Public40.2140.5737.1937.1237.25
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

71.39

MACD

65.94

50 DMA

733.94

200 DMA

470.51

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1509.601173.701061.50837.80725.60501.90166.00
Fibonacci1173.701045.39966.11837.80709.49630.21501.90
Camarilla1041.671010.88980.09837.80918.51887.72856.93

Pivots Level: Classic

R3

+671.80

1509.60

R2

+335.90

1173.70

R1

+223.70

1061.50

837.80
837.80
Pivot Point
LTP: 959.90

S1

-112.20

725.60

S2

-335.90

501.90

S3

-671.80

166.00

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    922.26

  • 20-EMA

    873.18

  • 30-EMA

    829.95

  • 50-EMA

    761.72

  • 100-EMA

    650.82

  • 200-EMA

    544.78

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
22 May 2026board-meetingsAccounts, Quarterly Results, Dividend
06 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
18 Sept 2025bonus1:1 Bonus Issue of Equity Shares03 Oct 2025
03 Sept 2025bonusBonus issue 1:103 Oct 2025
17 Aug 2025dividendFinal Dividend - Rs. - 117 Sept 2025
13 Aug 2025agm
26 May 2025dividend₹1.00 Dividend /Share17 Sept 2025
08 Aug 2024agm
06 Aug 2024agmAnnual General Meeting09 Sept 2024

Read More

Peer Comparison

Shilpa Medicare Ltd logo

Shilpa Medicare Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Read More

Shilpa Medicare Ltd About

Shilpa Medicare engaged in the manufacturing of API, Formulation and Development service.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Omprakash Inani

Employees

Contact

Website icon

Website

http://www.vbshilpa.com

Email icon

Email

info@vbshilpa.com

Phone icon

Phone

91-8532-238704

Location icon

Location

#12-6-214/A1, Hyderabad Road, Raichur, Karnataka, 584135

Read More

Shilpa Medicare Ltd Company History

YearHistory
2020
  • Shilpa Medicare Ltd launches first affordable generic drug to treat advanced kidney cancer.
  • Shilpa Medicare launches anti-cancer drug - IBRUSHIL.
  • Shilpa Medicare launched cancer drug at monthly therapy cost of Rs 6,440.
2021
  • Shilpa Medicare ties up with Cadila Healthcare for production of ZyCoV-D vaccine.
  • Shilpa Medicare arm inks pact with Dr Reddy s to manufacture Sputnik V vaccine.
  • Shilpa Medicare gets tentative USFDA nod for Apremilast tablets.
  • Shilpa Medicare Ltd has received Best District Export Excellence Award from FKCCI.
  • Shilpa Medicare launches Sunitinib Capsules under brand name SINISHIL.
2022
  • Shilpa Medicare Limited received NoC from RCGM, Dept. of Biotechnology for its Biosimilar Afliberce.
  • The Prestigious PEL-HEMSI AWARD presented to Polymer Research & Technology Group of Shilpa Medicare Limited.
2023
  • Shilpa Medicare Limited has launched ORAAL for the first time in India.
  • Shilpa Medicare s New Drug Application for Pemetrexed Injection 1000 mg/100 ml, 500 mg/50 ml & 100 mg/10 ml, Ready to Use formulation is approved by US FDA.
2024
  • Shilpa Medicare receives marketing authorization from Germany for Amifampridine tablets.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy547853683.0321 Mar 2025
UBS AGblockBuy163006818.0523 Jan 2025
UBS PRINCIPAL CAPITAL ASIA LIMITEDblockSell163006818.0523 Jan 2025
PLUTUS WEALTH MANAGEMENT LLPbulkBuy750000492.3405 Jun 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell482523444.0921 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy482523443.9521 Feb 2024
TA FII INVESTORS LIMITEDbulkSell500000422.2220 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy578067404.6319 Feb 2024
TA FII INVESTORS LIMITEDbulkSell1345000407.0519 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell578067404.4819 Feb 2024

Read More

Shilpa Medicare Ltd News

Shilpa Biologicals CEO resigns

Dr. Sridevi Khambhampaty resigned as CEO of Shilpa Biologicals Pvt Ltd effective July 15, 2026, due to personal commitments.

15 Jul 2026

companies

Shilpa Medicare FY26 net profit rises 96%

Shilpa Medicare reported a 96% rise in consolidated net profit to ₹2,433 crore for FY26. The Board recommended a final dividend of Re 0.60 per share.

04 Jul 2026

companies

Shilpa Medicare Signs Nivolumab Biosimilar Deal With Orion

Shilpa Medicare partners with Orion Corporation to develop and supply an EU-GMP biosimilar of Nivolumab for Europe, targeting the ~$4.1 billion PD-1 immunotherapy market.

30 Jun 2026

companies

Shilpa Medicare unit settles Rs 9 Cr dispute

Shilpa Biologicals settled a Rs 20 Cr claim with Sartorius Stedim India for Rs 9 Cr. The agreement was executed on June 23, 2026.

24 Jun 2026

companies

Shilpa Medicare commissions ADC GMP facility

Shilpa Medicare's subsidiary Shilpa Biologicals commissioned a state-of-the-art Antibody-Drug Conjugate GMP Manufacturing Facility. The facility is fully operational with GMP qualification protocols underway.

24 Jun 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Shilpa Medicare Ltd?

    As of 09/09/2026 at 1:55 AM, Shilpa Medicare Ltd shares are trading at ₹928.55.

  • 2.What is the market cap. of Shilpa Medicare Ltd?

    As of 09/09/2026, the market capitalization of Shilpa Medicare Ltd is ₹18,581.25 crore.

  • 3.When was Shilpa Medicare Ltd founded?

    Shilpa Medicare Ltd was founded in 1987.

  • 4.What are the P/E and P/B ratios of Shilpa Medicare Ltd?

    As of 09/09/2026, Shilpa Medicare Ltd has a P/E ratio of 61.08 and a P/B ratio of 2.73.

  • 5.How can I buy shares of Shilpa Medicare Ltd?

    You can buy shares of Shilpa Medicare Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Shilpa Medicare Ltd?

    As of March,2026, promoters hold 40.13% in Shilpa Medicare Ltd, while FIIs, DIIs and public shareholders hold 11.08%, 8.58% and 40.21%, respectively. The government holds 0.00%.

  • 7.Does Shilpa Medicare Ltd pay dividends?

    Yes, Shilpa Medicare Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 1 per share.

  • 8.What is the dividend yield of Shilpa Medicare Ltd?

    As of 09 September, 2026, the dividend yield of Shilpa Medicare Ltd stands at 0.05%.

  • 9.What are the latest financial results of Shilpa Medicare Ltd?

    For January,2024, Shilpa Medicare Ltd reported revenue of ₹1,285.00 crore and a net profit of ₹78.29 crore.

  • 10.What is the Stock symbol of Shilpa Medicare Ltd?

    SHILPAMED is the stock symbol of Shilpa Medicare Ltd.

  • 11.Who is the CEO of Shilpa Medicare Ltd?

    The CEO of Shilpa Medicare Ltd is Omprakash Inani.

Open Your Free Demat Account

Enter your phone number